We are developing a promising new technology based on extracellular vesicles (EVs, often referred to as exosomes), which are natural delivery vehicles produced by cells. These tiny particles have the potential to transform how we treat diseases by delivering therapeutic ingredients directly to where they’re needed in the body. To bring this technology to market […]
Read More